Delivery Order SPE2DB20D2104-SPE2DB23FU36V
- Not listed
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,209.55 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of PREVNAR 13 syringes, a pneumococcal vaccine, with a performance period through March 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $95,475.09, is for the delivery of PREVNAR 13 SYRINGE 0.5ML, a vaccine product. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,203.00, is for the delivery of PREVNAR 13 SYRINGE 0.5ML vaccine. It is a firm fixed price delivery order with a completion date of May 26, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award, valued at $7,268.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of PREVNAR 13 syringes, a pneumococcal vaccine, and has a final completion date of September 13, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a $41,257.07 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of PREVNAR 13 syringes (0.5 mL). This contract does not have a set-aside designation, indicating an open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier for federal healthcare programs, particularly within the Department of Defense and Department of Veterans Affairs. The...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $96,554.33, is for the delivery of PREVNAR 13 syringes (0.5mL) and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which specializes in the distribution of a wide range of...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $9,883.93 for the procurement of PREVNAR 13 syringes from Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 12, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates under the Amerisourcebergen brand. The company holds significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $82,131.81 firm fixed-price delivery order is for the supply of PREVNAR 13 SYRINGE 10S, a pneumococcal vaccine. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of Prevnar 13 syringes to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for $18,639.80. The contract has an ultimate completion date of February 10, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which specializes in pharmaceutical distribution and supplies a wide range of medical products to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,068.68, is for the delivery of PREVNAR 13 SYRINGE 0.5ML, a vaccine product. The contract has no set-aside designation, indicating it was awarded through open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU36VDelivery Order
This federal contract award, valued at $4,197.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREVNAR 13 syringes (0.5 mL), a pneumococcal conjugate vaccine, and has a period of performance through July 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which specializes in the distribution of a wide range of pharmaceutical products and medical supplies to government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 7/13/23 |